CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,085,000 | -78.9% | 140,218 | -64.8% | 0.01% | -78.3% |
| Q1 2019 | $9,886,000 | -44.1% | 398,275 | -59.6% | 0.02% | -51.1% |
| Q4 2018 | $17,700,000 | -44.1% | 985,503 | -8.5% | 0.05% | -30.9% |
| Q3 2018 | $31,637,000 | -42.5% | 1,077,183 | -10.9% | 0.07% | +7.9% |
| Q2 2018 | $54,986,000 | +5.7% | 1,209,308 | +22.8% | 0.06% | -47.9% |
| Q1 2018 | $52,006,000 | -61.2% | 984,973 | -50.0% | 0.12% | -18.8% |
| Q4 2017 | $133,930,000 | +96.5% | 1,969,566 | +138.1% | 0.15% | -5.1% |
| Q3 2017 | $68,157,000 | +25.7% | 827,155 | +42.8% | 0.16% | +23.6% |
| Q2 2017 | $54,235,000 | +613.7% | 579,243 | +385.4% | 0.13% | +605.6% |
| Q1 2017 | $7,599,000 | +296.0% | 119,342 | +176.4% | 0.02% | +260.0% |
| Q4 2016 | $1,919,000 | +16.4% | 43,185 | -5.5% | 0.01% | +25.0% |
| Q3 2016 | $1,648,000 | +128.9% | 45,698 | -12.9% | 0.00% | +100.0% |
| Q2 2016 | $720,000 | +37.7% | 52,467 | +92.7% | 0.00% | +100.0% |
| Q1 2016 | $523,000 | -52.7% | 27,223 | -13.8% | 0.00% | -50.0% |
| Q4 2015 | $1,106,000 | -76.4% | 31,596 | -54.9% | 0.00% | -85.7% |
| Q2 2013 | $4,689,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |